182 related articles for article (PubMed ID: 20658265)
1. Correlation between glycated hemoglobin and mean plasma glucose in hemodialysis patients.
Israel E; Geara A; Maarouf O; Ayoub I; Abi Rached J; Rizk S; Staynberg N; Samarneh M; El-Sayegh S
Int Urol Nephrol; 2011 Dec; 43(4):1149-53. PubMed ID: 20658265
[TBL] [Abstract][Full Text] [Related]
2. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
Sany D; Elshahawy Y; Anwar W
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
[TBL] [Abstract][Full Text] [Related]
3. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
[TBL] [Abstract][Full Text] [Related]
4. Glycemic control and survival of diabetic hemodialysis patients--importance of lower hemoglobin A1C levels.
Ishimura E; Okuno S; Kono K; Fujino-Kato Y; Maeno Y; Kagitani S; Tsuboniwa N; Nagasue K; Maekawa K; Yamakawa T; Inaba M; Nishizawa Y
Diabetes Res Clin Pract; 2009 Mar; 83(3):320-6. PubMed ID: 19135755
[TBL] [Abstract][Full Text] [Related]
5. Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients.
Mittman N; Desiraju B; Fazil I; Kapupara H; Chattopadhyay J; Jani CM; Avram MM
Kidney Int Suppl; 2010 Aug; (117):S41-5. PubMed ID: 20671744
[TBL] [Abstract][Full Text] [Related]
6. Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis.
Shurraw S; Majumdar SR; Thadhani R; Wiebe N; Tonelli M;
Am J Kidney Dis; 2010 May; 55(5):875-84. PubMed ID: 20346561
[TBL] [Abstract][Full Text] [Related]
7. Blood glucose fluctuations in hemodialysis patients with end stage diabetic nephropathy.
Jin YP; Su XF; Yin GP; Xu XH; Lou JZ; Chen JJ; Zhou Y; Lan J; Jiang B; Li Z; Lee KO; Ye L; Ma JH
J Diabetes Complications; 2015 Apr; 29(3):395-9. PubMed ID: 25681043
[TBL] [Abstract][Full Text] [Related]
8. Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis.
Nakao T; Matsumoto H; Okada T; Han M; Hidaka H; Yoshino M; Shino T; Yamada C; Nagaoka Y
Intern Med; 1998 Oct; 37(10):826-30. PubMed ID: 9840702
[TBL] [Abstract][Full Text] [Related]
9. Unique hemoglobin A1c level distribution and its relationship with mortality in diabetic hemodialysis patients.
Hoshino J; Larkina M; Karaboyas A; Bieber BA; Ubara Y; Takaichi K; Akizawa T; Akiba T; Fukuhara S; Pisoni RL; Saito A; Robinson BM
Kidney Int; 2017 Aug; 92(2):497-503. PubMed ID: 28396123
[TBL] [Abstract][Full Text] [Related]
10. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
Okuno S; Ishimura E; Tsuboniwa N; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Mori K; Nishizawa Y; Inaba M
Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
[TBL] [Abstract][Full Text] [Related]
11. Glycated albumin may be a choice, but not an alternative marker of glycated hemoglobin for glycemic control assessment in diabetic patients undergoing maintenance hemodialysis.
Chen FK; Sun XF; Zhang D; Cui SY; Chen XM; Wei RB; Lu JM; Li JJ; Liu WH; Zhang DL; Zhang ZM
Chin Med J (Engl); 2013; 126(17):3295-300. PubMed ID: 24033952
[TBL] [Abstract][Full Text] [Related]
12. Effects of Hemodialysis and Peritoneal Dialysis on Glycometabolism in Patients with End-Stage Diabetic Nephropathy.
Chen XX; Duan Y; Zhou Y
Blood Purif; 2021; 50(4-5):506-512. PubMed ID: 33302273
[TBL] [Abstract][Full Text] [Related]
13. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test.
Nagayama H; Inaba M; Okabe R; Emoto M; Ishimura E; Okazaki S; Nishizawa Y
Biomed Pharmacother; 2009 Mar; 63(3):236-40. PubMed ID: 18538530
[TBL] [Abstract][Full Text] [Related]
14. Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis.
Gallieni M; De Salvo C; Lunati ME; Rossi A; D'Addio F; Pastore I; Sabiu G; Miglio R; Zuccotti GV; Fiorina P
Acta Diabetol; 2021 Aug; 58(8):975-981. PubMed ID: 33743082
[TBL] [Abstract][Full Text] [Related]
15. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
[TBL] [Abstract][Full Text] [Related]
16. Glycemic control is a predictor of survival for diabetic patients on hemodialysis.
Morioka T; Emoto M; Tabata T; Shoji T; Tahara H; Kishimoto H; Ishimura E; Nishizawa Y
Diabetes Care; 2001 May; 24(5):909-13. PubMed ID: 11347753
[TBL] [Abstract][Full Text] [Related]
17. What is the Role of HbA1c in Diabetic Hemodialysis Patients?
Coelho S
Semin Dial; 2016; 29(1):19-23. PubMed ID: 26138753
[TBL] [Abstract][Full Text] [Related]
18. [Significance of hemoglobin A1C in the management of diabetes in dialysis patients].
Mácsai E; Rakk E; Miléder M; Fulcz A
Orv Hetil; 2014 Sep; 155(36):1421-5. PubMed ID: 25176516
[TBL] [Abstract][Full Text] [Related]
19. Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.
Emoto M; Tabata T; Inoue T; Nishizawa Y; Morii H
Nephron; 1992; 61(2):181-6. PubMed ID: 1630543
[TBL] [Abstract][Full Text] [Related]
20. [The value of fructosamine in hemodialysis patients].
Küenburg E; Brunnbauer M; Watzinger U; Winter F; Müller MM; Graf H; Prager R
Wien Klin Wochenschr Suppl; 1990; 180():11-3; discussion 32-3. PubMed ID: 2321384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
